Article
San Dimas, CA-Bausch & Lomb and InSite Vision will develop a fourth-generation fluoroquinolone that incorporates InSite Vision's drug delivery system, DuraSite.
Methylphenidate may impact corneal cells in children with ADHD
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ocular clues to multiple myeloma
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
Prevent Blindness declares April as Women’s Eye Health and Safety Month